In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor. Mondal R, Dusthackeer V N A, Kannan P, Singh AK, et al. PLoS One 2023;18:e0282454.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mondal R, Dusthackeer V N A, Kannan P, Singh AK, et al. In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor. PLoS One 2023;18:e0282454.
PMID: 36867599